Safety and tolerability of GRF6019 in mild‐to‐moderate Alzheimer's disease dementia
Abstract Introduction This phase 2 trial evaluated the safety, tolerability, and feasibility of repeated infusions of the plasma fraction GRF6019 in mild‐to‐moderate Alzheimer's disease. Methods In this randomized, double‐blind, dose‐comparison trial, 47 patients were randomized 1:1 to receive...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Alzheimer’s & Dementia: Translational Research & Clinical Interventions |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/trc2.12115 |